The inhibition of MSTN induced by gene manipulation or neutralizing antibodies improves sarcopenic obesity by increasing skeletal muscle mass and improving glucose homeostasis [1]. This evidence concerns the gene MSTN and obesity due to melanocortin 4 receptor deficiency.